Compounds > dichlororibofuranosylbenzimidazole
Page last updated: 2024-08-17

dichlororibofuranosylbenzimidazole and sb 203580

dichlororibofuranosylbenzimidazole has been researched along with sb 203580 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Anderson, A; Atfi, A; Gilot, D; Guillouzo, A; Joannard, F; Lagadic-Gossmann, D; Orfila-Lefeuvre, L; Rissel, M1
Derebecka-Holysz, N; Holysz, M; Lehmann, TP; Trzeciak, WH1

Other Studies

3 other study(ies) available for dichlororibofuranosylbenzimidazole and sb 203580

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Role for mitogen-activated protein kinases in phenobarbital-induced expression of cytochrome P450 2B in primary cultures of rat hepatocytes.
    Toxicology letters, 2006, Feb-08, Volume: 161, Issue:1

    Topics: Animals; Blotting, Northern; Butadienes; Cells, Cultured; Cytochrome P-450 CYP2B1; Dichlororibofuranosylbenzimidazole; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Hepatocytes; Imidazoles; Luciferases, Firefly; Male; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mutation; Nitriles; p38 Mitogen-Activated Protein Kinases; Phenobarbital; Phosphorylation; Pyridines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transfection

2006
TGF-beta inhibits CYP17 transcription in H295R cells acting via activin receptor-like kinase 5.
    Endocrine research, 2009, Volume: 34, Issue:3

    Topics: Activin Receptors; Adrenal Cortex; Benzamides; Cell Line; Colforsin; Cytochromes b5; Dichlororibofuranosylbenzimidazole; Dioxoles; Humans; Imidazoles; MAP Kinase Kinase 1; NADPH-Ferrihemoprotein Reductase; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyridines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; RNA, Messenger; Steroid 17-alpha-Hydroxylase; Transforming Growth Factor beta

2009